Recurrent stone formers-metabolic evaluation: a must investigation
DOI:
https://doi.org/10.18203/2349-2902.isj20163972Keywords:
Metabolic stone, Recurrent stone, StoneAbstract
Background:The lifetime prevalence of kidney stone disease is estimated at 1% to 15% and the mean rate of recurrence of stone is estimated to be 30% at 5 years, 50% at 10 years and 80% at 20 years. Symptomatic urinary calculus can cause considerable discomfort to the patient. The aim of the study was to evaluate the various serum and urinary parameters.
Methods: 50 patients with history of renal stones coming to SGRDIMSR were evaluated for various serum and urinary parameters.
Results:Serum calcium, sodium, phosphorus, potassium, B. urea, S. creatinine is higher than normal in patients with recurrent renal calculi. Most of the urinary parameters were also similar to studies stating that they have a pivotal role in recurrent stone formers.
Conclusions:For the frequent stone formers and even for some first time stone formers interested in preventing future episodes of renal colic, a metabolic evaluation is necessary. Besides identifying the abnormality, the evaluation also helps determine the drug choices and dosages.
References
Pearle MS, Lotan Y. Urinary lithiasis: etiology, epidemiology, and pathogenesis. In: Wein AJ, Kavousi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh Urology. 10th Ed. Philadelphia: Saunders; 2007: 1257-86.
Asplin, Chandoke. The stone forming patient. In: Coe FL, editor. Kidney stones: medical and surgical management. Philadelphia: Lippincot Raven; 1996: 335-7.
Curhan G, Willett W, Rimm E. Family history and risk of kidney stones. J Am Soc Nephrol. 1997;8:1568-73.
Tiselius HG, Ackermann D, Alken P, Buck C, Conort P, Gallucci M. Guidelines on urolithiasis. Eur Urol. 2001;40:362-71.
Hodgkinson A, Pyrah LN. The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin. Br J Surg. 1958;46(195):10-8.
Curhan GC, Willett WC, Speizer FE. Twenty four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int. 2001;59(6):2290-8.
Coe FL. Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int. 1978;13(5):418-26.
Eng J. Sample size estimation: How many Individuals Should be Studied? Radiology. 2007;227:309-13.
Johnson CM, Wilson DM, O’Fallon WM. Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int. 1979;16(5):624-31.
Borghi L, Schianchi T, Meschi T. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346(2):77-84.
Griffith DP, Osborne CA. Infection (urease) stones. Miner Electrolyte Metab. 1987;13:278-85.
Erdamar H, Sancak B, Bukan N, Pasaoglu H. Relationship between 24 hour urine and serum parameters in patients with Nephrolithiasis. Firat Tip Dergisi. 2007;12:37-40.
Parks JH, Goldfisher E, Asplin JR, Coe FL. A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol. 2002;167:1607-12.
Hosseini MM, Eshraghian A, Dehghanian I, Amini M. Metabolic abnormalities in patients with nephrolithiasis: comparison of first-episode with recurrent cases in Southern Iran. Int Urol Nephrol. 2010;42:127-31.
Stitchantrakul W, Kochakarn W, Ruangraksa C, Domrongkitchaiporn S. Urinary risk factors for recurrent calcium stone formation in Thai stone formers. J Med Assoc Thai. 2007;90:688-97.
Ha YS. Phosphaturia as a promising predictor of recurrent stone formation in patients with urolithiasis. Korean J Urol. 2010;51:54-9.
Mittal RD, Kumar R. Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium oxalobacter formigenes as risk factors for renal stone formation. Med Princ Pract. 2003;12:208-13.
Nandwani GM, Stoves J, Azhar MF, Pereni Cl, Shah T. Metabolic abnormalities in patients treated with percutaneous nephrolithotomy. J Clin Urol. 2015;8:6374-82.
